Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections
…, M Zavattoni, M Furione, D Lilleri… - The Journal of …, 2002 - academic.oup.com
Primary human cytomegalovirus (HCMV) infection occurring in pregnant women within 3
months before (preconceptional) or within 4 weeks after (periconceptional) the last menstrual …
months before (preconceptional) or within 4 weeks after (periconceptional) the last menstrual …
Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131–128 genes and mediates efficient viral antigen presentation to …
G Gerna, E Percivalle, D Lilleri… - Journal of General …, 2005 - microbiologyresearch.org
Human cytomegalovirus (HCMV) genetic determinants of endothelial-cell tropism and virus
transfer to leukocytes (both polymorphonuclear and monocyte) have been recently identified …
transfer to leukocytes (both polymorphonuclear and monocyte) have been recently identified …
[HTML][HTML] Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in∼ 40% of patients
…, F Trespidi, E Burdino, I Cassaniti, D Lilleri… - Journal of Experimental …, 2023 - rupress.org
Mosquito-borne West Nile virus (WNV) infection is benign in most individuals but can cause
encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for …
encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for …
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer
Human cytomegalovirus encodes at least 25 membrane glycoproteins that are found in the
viral envelope 1. While gB represents the fusion protein, two glycoprotein complexes control …
viral envelope 1. While gB represents the fusion protein, two glycoprotein complexes control …
[HTML][HTML] Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection
D Lilleri, A Kabanova, MG Revello, E Percivalle… - PloS one, 2013 - journals.plos.org
Primary human cytomegalovirus (HCMV) infections during pregnancy are associated with a
high risk of virus transmission to the fetus. To identify correlates of intrauterine HCMV …
high risk of virus transmission to the fetus. To identify correlates of intrauterine HCMV …
Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events
…, S Sozzani, P Lanzarini, E Genini, D Lilleri… - Journal of …, 2000 - Am Soc Microbiol
Using a recently developed model for in vitro generation of pp65-positive polymorphonuclear
leukocytes (PMNLs), we demonstrated that PMNLs from immunocompetent subjects may …
leukocytes (PMNLs), we demonstrated that PMNLs from immunocompetent subjects may …
Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience
…, E Fabbri, M Furione, M Zavattoni, D Lilleri… - Journal of clinical …, 2011 - Elsevier
BACKGROUND: The burden of congenital human cytomegalovirus (HCMV) infection is well
recognized. However, screening for maternal infection remains controversial in view of …
recognized. However, screening for maternal infection remains controversial in view of …
[HTML][HTML] New advances in CMV and immunosenescence
…, M Hurme, F Kern, D Lilleri… - Experimental …, 2014 - Elsevier
Immunosenescence, defined as the age-associated dysregulation and dysfunction of the
immune system, is characterized by impaired protective immunity and decreased efficacy of …
immune system, is characterized by impaired protective immunity and decreased efficacy of …
Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies
A Kabanova, L Perez, D Lilleri… - Proceedings of the …, 2014 - National Acad Sciences
The use of neutralizing antibodies to identify the most effective antigen has been proposed
as a strategy to design vaccines capable of eliciting protective B-cell immunity. In this study, …
as a strategy to design vaccines capable of eliciting protective B-cell immunity. In this study, …
[HTML][HTML] Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome
…, E Cova, F Mojoli, P Bergomi, D Ottolina, D Lilleri… - BMC pulmonary …, 2020 - Springer
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly reached
pandemic proportions. Given that the main target of SARS-CoV-2 are lungs leading to …
pandemic proportions. Given that the main target of SARS-CoV-2 are lungs leading to …
